Martin Münchbach

Pureos Bioventures thesis

Prof. Dr. Thomas Baumert Advisory Board Thomas is a founder and advisor of Alentis Therapeutics and is an internationally renowned gastroenterologist with 25 years of R&D experience in fundamental, translational and clinical research. Thomas developed novel preventive and therapeutic strategies for fibrosis and cancer as well as underlying viral diseases. He has published more than 400 articles in leading scientific journals and led more than 50 research programs in fibrosis, cancer and virology. He is a Professor of Medicine, Gastroenterologist and head of the Inserm Institute IVH at the Univ

Sector and stage focus

• Seed: Pharmaceuticals, BioTech, Therapeutics
• Series A: BioTech, Pharmaceuticals, Therapeutics

Is Martin Münchbach a fit for your round?

Upload your pitch deck and see whether Martin Münchbach appears in your top 20 matches.